INVO Fertility, Inc.
IVF
$1.60
$0.117.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 89.31% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 89.31% | -- | -- | -- | |
| Cost of Revenue | 93.03% | -- | -- | -- | |
| Gross Profit | 84.27% | -- | -- | -- | |
| SG&A Expenses | 74.00% | -- | -- | -- | |
| Depreciation & Amortization | 76.09% | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 84.61% | -- | -- | -- | |
| Operating Income | -79.42% | -- | -- | -- | |
| Income Before Tax | -170.90% | -- | -- | -- | |
| Income Tax Expenses | -142.33% | -- | -- | -- | |
| Earnings from Continuing Operations | -168.63% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -196.42% | -- | -- | -- | |
| EBIT | -79.42% | -- | -- | -- | |
| EBITDA | -170.99% | -- | -- | -- | |
| EPS Basic | 21.06% | -- | -- | -- | |
| Normalized Basic EPS | 50.42% | -- | -- | -- | |
| EPS Diluted | 21.05% | -- | -- | -- | |
| Normalized Diluted EPS | 50.42% | -- | -- | -- | |
| Average Basic Shares Outstanding | 2,035.77% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 2,035.77% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |